| Bioactivity | MOG peptide (35-55) is a fragment 35-55 of myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide. MOG peptide (35-55) is specific to expanded CD4+ T cells, and induces experimental autoimmune encephalomyelitis (EAE) in animal model[1][2][3]. |
| Invitro | The expanded CD4+ T cells are largely specific for the myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide 35-55 (MOG35-55), while clonally expanded CD8+ T cells were non-responsive to myelin peptides or proteins[1]. |
| Name | MOG peptide (35-55) |
| CAS | 2022956-48-3 |
| Shortening | MEVGWYRSPFSRVVHLYRNGK-NH2 |
| Formula | C118H178N36O28S |
| Molar Mass | 2580.97 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
MOG peptide (35-55)
CAS: 2022956-48-3 F: C118H178N36O28S W: 2580.97
MOG peptide (35-55) is a fragment 35-55 of myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide. MOG peptide (3
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.